Navigation Links
Auxilium Pharmaceuticals, Inc. Announces Promotion of Dr. James P. Tursi to Chief Medical Officer
Date:8/8/2011

release contains "forward-looking-statements" within the meaning of The Private Securities Litigation Reform Act of 1995, including statements regarding the leadership and experience that Dr. Tursi will bring to the position of Chief Medical Officer; products in development for Dupuytren's contracture, Peyronie's disease, and Frozen Shoulder syndrome; and the potential for XIAFLEX to be used in multiple indications.  

Forward-looking statements often address Auxilium's expected future financial position or business strategy and plans and objectives of management for future operations. Forward-looking statements provide Auxilium's current expectations or forecasts of future events. Auxilium's performance and financial results could differ materially from those reflected in these forward-looking statements due to various risks and uncertainties.

A more detailed list and description of the risks and uncertainties that Auxilium faces may be found under the heading "Risk Factors" in Auxilium's Annual Report on Form 10-K for the year ended December 31, 2010 and Form 10-Q for the quarter ended June 30, 2011, which are on file with the Securities and Exchange Commission. Given these risks and uncertainties, any or all of the forward-looking statements contained in this release may prove to be incorrect. Therefore, you should not rely on any such factors or forward-looking statements. Auxilium undertakes no obligation to update publicly any forward-looking statement.

CONTACT:
James E. Fickenscher
Chief Financial Officer, Auxilium Pharmaceuticals, Inc.
+1-484-321-5900
jfickenscher@auxilium.com
or
William Q. Sargent Jr.
Vice-President, Investor Relations and Corporate Communications
+1-484-321-5900
wsargent@auxilium.com


'/>"/>
SOURCE Auxilium Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
2. Auxilium Pharmaceuticals, Inc. Announces XIAFLEX(TM) Meets Primary Endpoint With Statistical Significance (p<0.001) in CORD I Pivotal Phase III Study for Dupuytrens Contracture
3. BioSpecifics Technologies Corp. Announces Auxilium XIAFLEX® Update
4. Auxilium Pharmaceuticals, Inc. Announces Initiation of XIAFLEX® Phase III Studies for Peyronies Disease
5. Auxilium Pharmaceuticals, Inc. Announces Issuance of Patent for Clostridial Collagenase
6. Auxilium Pharmaceuticals to Present at the 2010 Annual Credit Suisse Healthcare Conference
7. Auxilium Pharmaceuticals Reports Preliminary Fourth Quarter 2010 Net Revenue and Announces 2011 XIAFLEX Revenue Guidance
8. Auxilium Pharmaceuticals to Present at the 2011 Citi Annual Global Healthcare Conference
9. Auxilium Pharmaceuticals to Present at the Cowen and Company 31st Annual Health Care Conference
10. Auxilium Pharmaceuticals, Inc. Completes Enrollment of XIAFLEX® Phase III Double-Blind Studies for Peyronies Disease
11. Auxilium Pharmaceuticals, Inc. and Asahi Kasei Pharma Corporation Enter Agreement to Develop, Commercialize and Supply XIAFLEX® In Japan
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/26/2014)... 26, 2014 Using publicly released 2015 rate ... costs for five common specialty drugs. Specialty drugs ... their high costs and shortage of generic alternatives. ... per prescription, and are used for a broad ... sclerosis. HealthPocket found that among ...
(Date:8/26/2014)... SAN DIEGO , Aug. 26, 2014 /PRNewswire/ ... Sorrento), a late-stage clinical oncology company developing new ... announced that it has received funding to advance ... the potential treatment of IPF, which affects more ... in the lungs increases and patients gradually lose ...
(Date:8/26/2014)... LONDON , August 26, 2014 ... http://www.fdna.com ) and London Medical Databases Ltd. ( http://www.lmdatabases.com ... for the first time, online access to the award ... developer of the Facial Dysmorphology Novel Analysis ... [ TM ] , the only available ...
Breaking Medicine Technology:2015 Platinum Plans Are Best Buy for Consumers Using Expensive Specialty Drugs 2Sorrento Awarded NIH Grant to Advance Immunotherapy Targeting Idiopathic Pulmonary Fibrosis (IPF) 2Sorrento Awarded NIH Grant to Advance Immunotherapy Targeting Idiopathic Pulmonary Fibrosis (IPF) 3FDNA Partners with London Medical Databases (LMD) to Provide Long-Awaited Online Access to Leading Dysmorphology Database 2FDNA Partners with London Medical Databases (LMD) to Provide Long-Awaited Online Access to Leading Dysmorphology Database 3
... Perrigo Company (Nasdaq: PRGO; TASE) today announced that ... all of the assets of Paddock Laboratories, Inc. ("Paddock"), ... products for approximately $540 million in cash. Perrigo expects ... of the acquisition of Paddock,s assets. The net present ...
... Reportlinker.com announces that a new market research ... Hospital Angiography Census ... comprehensive European market report on the installed base ... Angiography, CT, MRI,) and radiology IT systems (PACS, ...
Cached Medicine Technology:Perrigo to Acquire Assets of Paddock Labs for $540 Million 2Perrigo to Acquire Assets of Paddock Labs for $540 Million 3Perrigo to Acquire Assets of Paddock Labs for $540 Million 4Perrigo to Acquire Assets of Paddock Labs for $540 Million 5Reportlinker Adds Hospital Angiography Census 2Reportlinker Adds Hospital Angiography Census 3
(Date:8/27/2014)... StartX , a nonprofit technology accelerator ... a pioneering institute driving biotechnology innovation at the University ... laboratory customized for the needs of early stage medical ... lab space, named “StartX-QB3 Labs,” is the first research ... Care focused on developing entrepreneurs from academia to industry. ...
(Date:8/27/2014)... NY (PRWEB) August 27, 2014 For ... a new face on plastic surgery when triple-board certified, ... art – figurative clay sculptures he has created from ... precision, authority and artistry at a unique event on ... Space located at 23 Warren Street. The “faces” who ...
(Date:8/27/2014)... (PRWEB) August 27, 2014 Humility of ... program at St. Elizabeth Boardman Health Center in Boardman ... Mall in Niles beginning Sept. 8. , SlimDown teaches ... with regard to food, physical activity and behavior. , ... St. Elizabeth Boardman Health Center and Mondays at St. ...
(Date:8/27/2014)... 27, 2014 Two of Woodland Hills’ ... Jivraj of the Anacapa Dental Art Institute, deal with serious ... complex oral surgery. , So patients can be reluctant to ... sores left from biting their lip or gums. , “The ... by the accidental bite,” Dr. Reshad said. “This canker or ...
(Date:8/27/2014)... 2014 A recent news article in ... list of “Five tips for relieving dry skin.” Sharon ... Kleyne Hour Power of Water radio show describes the ... tips that are seldom reported but which, Kleyne believes, ... Sharon Kleyne is Founder of Bio Logic Aqua Research, ...
Breaking Medicine News(10 mins):Health News:StartX & QB3 Launch Lab for Life Science and Medical Technology Entrepreneurs 2Health News:StartX & QB3 Launch Lab for Life Science and Medical Technology Entrepreneurs 3Health News:StartX & QB3 Launch Lab for Life Science and Medical Technology Entrepreneurs 4Health News:Presenting A Remarkable Fusion of Art, Fashion and Plastic Surgery 2Health News:Humility of Mary Health Partners Offers SlimDown Classes 2Health News:Two of Ventura’s Best Cosmetic Dentists Offer 5 Tips for Dealing with Frequent Tongue or Lip Biting 2Health News:Two of Ventura’s Best Cosmetic Dentists Offer 5 Tips for Dealing with Frequent Tongue or Lip Biting 3Health News:Two of Ventura’s Best Cosmetic Dentists Offer 5 Tips for Dealing with Frequent Tongue or Lip Biting 4Health News:Two of Ventura’s Best Cosmetic Dentists Offer 5 Tips for Dealing with Frequent Tongue or Lip Biting 5Health News:Water Advocate Sharon Kleyne Reports New Discoveries for Relief of Dry Dehydrated Skin 2Health News:Water Advocate Sharon Kleyne Reports New Discoveries for Relief of Dry Dehydrated Skin 3
... by a Holyrood committee’s call for a public inquiry into ... NHS treatments has created ripples.// ,This was the ... reason for limited efforts to track down patients infected with ... inquiry by just one casting vote from convener Roseanna Cunningham. ...
... Journal of Preventive Medicine in its May issue has ... don’t exercise enough, which is highly recommended by the ... ,“People with arthritis are not meeting physical ... experts in the arthritis field,” said co-author Jennifer Hootman, ...
... diet and ALS saying that a ketogenic- high caloric ... (ALS). // The Mount Sinai School of Medicine is ... neuronal cell death, the cause of ALS. ,According ... which spinal and cortical motor neurons die causing relentlessly ...
... May issue of the American Journal of Preventive Medicine, researchers ... // and research on the reason as to why more ... that this was because of obesity which plays a major ... ,The researchers felt that the lifestyle interventions that can be ...
... to be effective in reducing chest pain, not associated ... pain have no identifiable cause // for their pain. ... be severely bothered by their symptom. Particularly, young women ... ,It is not known exactly what causes non-cardiac pain. ...
... was conducted by the London School of Hygiene, to access ... it was found that serious gaps in some national plans ... Italy, Latvia, Lithuania, Romania, Poland and Portugal were the least ... to plan in such a way that they need to ...
Cached Medicine News:Health News:Most People With Arthritis Do Little Or No Exercise At All 2Health News:Obesity The Major Cause Of The Increase In Newly Diagnosed Diabetes 2Health News:Non-Cardiac Chest Pain Can Be Treated By Hypnotherapy 2Health News:Joint Effort among Various Nations to Tackle Bird Flu 2
...
1.7% Tryptone, 0.3% Soytone, 0.5% Sodium Chloride, 0.25% Dextrose, 0.25% Potassium Phosphate....
... The basic Thermomixer is a compact model ... 24 x 1.5 ml tubes. Impressive features ... clear design, and high stabilityeven at maximum ... for gentle to vigorous mixing, including intermittent ...
... Penicillin/25,000 ug Streptomycin All ... and Buffer products are ... cGMP regulations and are ... assure compatibility. , Typical ...
Medicine Products: